menu
    • menu

    Company profile for Boryung Pharmaceutical Co., Ltd

    NEW Drugs in Dev: 47
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Boryung Pharmaceutical, aiming at the best not the biggest, started from the pharmacy since 1957 and has put a strong presence in Korean market as one of TOP leading pharmaceutical companies. Boryung has invested continually on research and development and made continuous efforts to produce high-quality products. Lately by developing new drug of Fimasartan(new chemical entity by Boryung's technology) with its own R&D, Boryung ...
    Boryung Pharmaceutical, aiming at the best not the biggest, started from the pharmacy since 1957 and has put a strong presence in Korean market as one of TOP leading pharmaceutical companies. Boryung has invested continually on research and development and made continuous efforts to produce high-quality products. Lately by developing new drug of Fimasartan(new chemical entity by Boryung's technology) with its own R&D, Boryung is accelerating its R&D activity to become global health care company. Also, synthetic API's & oncology formulation are core competence and have been attractive to many customers in regulated & non-regulated markets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Boryung Pharmaceutical Co., Ltdkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    Boryeong Building, 136, Changgyeonggung-ro, Jongno-gu, Seoul
    Telephone
    Telephone
    82 274 043 47
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://boryung.co.kr/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Boryung Picks Up Taxotere Rights In Deal Worth Up To $205M
    Boryung Picks Up Taxotere Rights In Deal Worth Up To $205M

    30 Sep 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/south-koreas-boryung-looks-stir-new-value-sanofis-legacy-taxotere-chemo-205m-buy

    FIERCE PHARMA
    30 Sep 2025
    Share Share
    Boryung, Samsung Bioepis launch Avastin biosimilar
    Boryung, Samsung Bioepis launch Avastin biosimilar

    31 Aug 2021

    // Lee Han-soo KOREABIOMED

    http://www.koreabiomed.com/news/articleView.html?idxno=12046

    Lee Han-soo KOREABIOMED
    31 Aug 2021
    Share Share
    Boryung‘s blood pressure drug Kanarb reduces risk of strokes, vascular events
    Boryung‘s blood pressure drug Kanarb reduces risk of strokes, vascular events

    03 Aug 2021

    // KOREAHERALD

    http://www.koreaherald.com/view.php?ud=20210803000853

    KOREAHERALD
    03 Aug 2021
    Share Share
    Boryung , PharmaMar’s partner in South Korea, announces superior potent results
    Boryung , PharmaMar’s partner in South Korea, announces superior potent results

    02 Jul 2020

    // PHARMAMAR.COM/WP-CONTENT/UPLOADS/2020/07/PR_PLITIDEPSIN_IN_VITRO_RESULTS_KOREA_OK

    http://pharmamar.com/wp-content/uploads/2020/07/PR_plitidepsin_in_vitro_results_Korea_OK.pdf

    PHARMAMAR.COM/WP-CONTENT/UPLOADS/2020/07/PR_PLITIDEPSIN_IN_VITRO_RESULTS_KOREA_OK
    02 Jul 2020
    Share Share
    Local drug makers strive to conquer neurological diseases
    Local drug makers strive to conquer neurological diseases

    10 Jul 2018

    // So Jae-hyeon KOREA BIOMED

    http://www.koreabiomed.com/news/articleView.html?idxno=3686

    So Jae-hyeon KOREA BIOMED
    10 Jul 2018
    Share Share
    Korea's Boryung Pharmaceuticals to launch two antihypertensive drugs in SE Asia
    Korea's Boryung Pharmaceuticals to launch two antihypertensive drugs in SE Asia

    13 Oct 2017

    // BIOSPECTRUM

    https://www.biospectrumasia.com/news/25/9586/koreas-boryung-pharmaceuticals-to-launch-two-antihypertensive-drugs-in-se-asia.html

    BIOSPECTRUM
    13 Oct 2017
    Share Share

    ABOUT THIS PAGE

    Contact Boryung Pharmaceutical Co., Ltd and get a quotation

    Boryung Pharmaceutical Co., Ltd is a supplier offers 19 products (APIs, Excipients or Intermediates).

    Find Alacepril bulk with JDMF offered by Boryung Pharmaceutical Co., Ltd

    Find Dasatinib bulk with JDMF offered by Boryung Pharmaceutical Co., Ltd

    Find Doxorubicin Hydrochloride bulk with CEP offered by Boryung Pharmaceutical Co., Ltd

    Find Montelukast Sodium bulk with JDMF offered by Boryung Pharmaceutical Co., Ltd

    Find Pitavastatin bulk with JDMF offered by Boryung Pharmaceutical Co., Ltd

    Find Tamsulosin bulk with JDMF offered by Boryung Pharmaceutical Co., Ltd

    Find Doxorubicin Hydrochloride bulk offered by Boryung Pharmaceutical Co., Ltd

    Find Aripiprazole bulk offered by Boryung Pharmaceutical Co., Ltd

    Find Cilnidipine bulk offered by Boryung Pharmaceutical Co., Ltd

    Find Dapagliflozin bulk offered by Boryung Pharmaceutical Co., Ltd

    Find Donepezil bulk offered by Boryung Pharmaceutical Co., Ltd

    Find Edoxaban Tosylate bulk offered by Boryung Pharmaceutical Co., Ltd

    Find Empagliflozin bulk offered by Boryung Pharmaceutical Co., Ltd

    Find Fesoterodine bulk offered by Boryung Pharmaceutical Co., Ltd

    Find Fexofenadine Hydrochloride bulk offered by Boryung Pharmaceutical Co., Ltd

    Find Fimasartan bulk offered by Boryung Pharmaceutical Co., Ltd

    Find Lafutidine bulk offered by Boryung Pharmaceutical Co., Ltd

    Find Linezolid bulk offered by Boryung Pharmaceutical Co., Ltd

    Find Torsemide bulk offered by Boryung Pharmaceutical Co., Ltd

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search